Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trials

Sarah K. Lageman, Jane H Cerhan, Dona E Locke, S. Keith Anderson, Wenting Wu, Paul D. Brown

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Neuropsychological tests are increasingly being used as outcome measures in clinical trials of brain tumor therapies. This study informs development of brief neurocognitive batteries for clinical trials by identifying cognitive tasks that detect effects on a group level in a mixed brain tumor population. This is a retrospective study of brain tumor patients who completed a standardized battery sampling multiple cognitive domains using twelve subtests with widely-used task formats (the Repeatable Battery for the Assessment of Neuropsychological Status). Sixty-eight patients with brain tumors were studied (60% high-grade glioma). Forty patients (58.8%) were impaired (>2 standard deviations below published means) on at least one subtest. A combination of four subtests (Figure Copy, Coding, List Recognition, and Story Recall) captured 90% of the impaired subgroup. These results suggest visuoconstruction, processing speed, and verbal memory measures may be the most important domains to assess when evaluating cognitive change in brain tumor clinical trials.

Original languageEnglish (US)
Pages (from-to)271-276
Number of pages6
JournalJournal of Neuro-Oncology
Volume96
Issue number2
DOIs
StatePublished - Jan 2010

Fingerprint

Brain Neoplasms
Clinical Trials
Neuropsychological Tests
Glioma
Retrospective Studies
Outcome Assessment (Health Care)
Population
Therapeutics

Keywords

  • Brain tumor
  • Clinical trials
  • Neurocognition
  • RBANS

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neurology

Cite this

Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trials. / Lageman, Sarah K.; Cerhan, Jane H; Locke, Dona E; Anderson, S. Keith; Wu, Wenting; Brown, Paul D.

In: Journal of Neuro-Oncology, Vol. 96, No. 2, 01.2010, p. 271-276.

Research output: Contribution to journalArticle

Lageman, Sarah K. ; Cerhan, Jane H ; Locke, Dona E ; Anderson, S. Keith ; Wu, Wenting ; Brown, Paul D. / Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trials. In: Journal of Neuro-Oncology. 2010 ; Vol. 96, No. 2. pp. 271-276.
@article{2e72562081a54c05ab8755ee271a126d,
title = "Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trials",
abstract = "Neuropsychological tests are increasingly being used as outcome measures in clinical trials of brain tumor therapies. This study informs development of brief neurocognitive batteries for clinical trials by identifying cognitive tasks that detect effects on a group level in a mixed brain tumor population. This is a retrospective study of brain tumor patients who completed a standardized battery sampling multiple cognitive domains using twelve subtests with widely-used task formats (the Repeatable Battery for the Assessment of Neuropsychological Status). Sixty-eight patients with brain tumors were studied (60{\%} high-grade glioma). Forty patients (58.8{\%}) were impaired (>2 standard deviations below published means) on at least one subtest. A combination of four subtests (Figure Copy, Coding, List Recognition, and Story Recall) captured 90{\%} of the impaired subgroup. These results suggest visuoconstruction, processing speed, and verbal memory measures may be the most important domains to assess when evaluating cognitive change in brain tumor clinical trials.",
keywords = "Brain tumor, Clinical trials, Neurocognition, RBANS",
author = "Lageman, {Sarah K.} and Cerhan, {Jane H} and Locke, {Dona E} and Anderson, {S. Keith} and Wenting Wu and Brown, {Paul D.}",
year = "2010",
month = "1",
doi = "10.1007/s11060-009-9960-y",
language = "English (US)",
volume = "96",
pages = "271--276",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "2",

}

TY - JOUR

T1 - Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trials

AU - Lageman, Sarah K.

AU - Cerhan, Jane H

AU - Locke, Dona E

AU - Anderson, S. Keith

AU - Wu, Wenting

AU - Brown, Paul D.

PY - 2010/1

Y1 - 2010/1

N2 - Neuropsychological tests are increasingly being used as outcome measures in clinical trials of brain tumor therapies. This study informs development of brief neurocognitive batteries for clinical trials by identifying cognitive tasks that detect effects on a group level in a mixed brain tumor population. This is a retrospective study of brain tumor patients who completed a standardized battery sampling multiple cognitive domains using twelve subtests with widely-used task formats (the Repeatable Battery for the Assessment of Neuropsychological Status). Sixty-eight patients with brain tumors were studied (60% high-grade glioma). Forty patients (58.8%) were impaired (>2 standard deviations below published means) on at least one subtest. A combination of four subtests (Figure Copy, Coding, List Recognition, and Story Recall) captured 90% of the impaired subgroup. These results suggest visuoconstruction, processing speed, and verbal memory measures may be the most important domains to assess when evaluating cognitive change in brain tumor clinical trials.

AB - Neuropsychological tests are increasingly being used as outcome measures in clinical trials of brain tumor therapies. This study informs development of brief neurocognitive batteries for clinical trials by identifying cognitive tasks that detect effects on a group level in a mixed brain tumor population. This is a retrospective study of brain tumor patients who completed a standardized battery sampling multiple cognitive domains using twelve subtests with widely-used task formats (the Repeatable Battery for the Assessment of Neuropsychological Status). Sixty-eight patients with brain tumors were studied (60% high-grade glioma). Forty patients (58.8%) were impaired (>2 standard deviations below published means) on at least one subtest. A combination of four subtests (Figure Copy, Coding, List Recognition, and Story Recall) captured 90% of the impaired subgroup. These results suggest visuoconstruction, processing speed, and verbal memory measures may be the most important domains to assess when evaluating cognitive change in brain tumor clinical trials.

KW - Brain tumor

KW - Clinical trials

KW - Neurocognition

KW - RBANS

UR - http://www.scopus.com/inward/record.url?scp=75049085637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75049085637&partnerID=8YFLogxK

U2 - 10.1007/s11060-009-9960-y

DO - 10.1007/s11060-009-9960-y

M3 - Article

VL - 96

SP - 271

EP - 276

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 2

ER -